Prof. James Giordano, PhD, Director of the Potomac Institute for Policy Studies' Center for Neurotechnology Studies, writes in the March 2010 issue of Practical Pain Management about the prevalence of neurotechnology-based devices on the market today. Dr. Giordano writes that neurotechnology, including neurofeedback, has valid applications in a medical setting but is currently being marketed to the public by poorly trained technicians and non-professionals. He writes, "Simply put, there is indubitably great value of neurotechnology in pain care, but neurotechnological progress should not be ethically undermined by capricious, unprofessional utilization engendered through improper education, training and/or misdirection by market forces." Click below to read the article in full.